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Direct visualization of HIV-1 replication would
improve our understanding of the viral life cycle.
We adapted established technology and reagents
to develop an imaging approach, ViewHIV, which
allows evaluation of early HIV-1 replication inter-
mediates, from reverse transcription to integration.
These methods permit the simultaneous evaluation
of both the capsid protein (CA) and viral DNA genome
(vDNA) components of HIV-1 in both the cytosol
and nuclei of single cells. ViewHIV is relatively rapid,
uses readily available reagents in combination with
standard confocal microscopy, and can be done
with virtually anyHIV-1 strain andpermissive cell lines
or primary cells. Using ViewHIV, we find that CA en-
ters the nucleus and associates with vDNA in both
transformed and primary cells. We also find that
CA’s interaction with the host polyadenylation fac-
tor, CPSF6, enhances nuclear entry and potentiates
HIV-1’s depth of nuclear invasion, potentially aiding
the virus’s integration into gene-dense regions.
INTRODUCTION
How HIV-1 overcomes our defenses and infects our cells has
been studied intensively for over 30 years. While much has
been learned, there remain events in the viral life cycle that resist
interrogation. One such area is the initial intra-nuclear portion of
infection, from the virus’s nuclear entry to its integration into
chromatin. We reasoned that an image-based method would
be useful for investigating this phase, and so we set about to
develop methods that would permit the direct visualization of
these early events.
Infection commences with HIV-1’s binding to the host recep-
tors, progressing to fusion of the host and viral membranes
and entry of the viral core into the cytosol. A conical-shapedCell Repassembly comprised of 250 hexamers and 12 pentamers of
capsid protein (CA; Ganser-Pornillos et al., 2007), the core con-
tains two copies of the virus’s RNA genome, reverse transcrip-
tase (RT) and integrase (IN). After entry, the core partially uncoats
to produce the reverse transcription complex (RTC), wherein RT
synthesizes the viral DNA genome (vDNA). HIV-1s with CAmuta-
tions have shown that the efficiency of reverse transcription
depends on the kinetics of core uncoating (Hulme et al.,
2015b; Xu et al., 2013; Yang et al., 2013). The vDNA and its
accompanying proteins are referred to as the preintegration
complex (PIC). Associating with microtubules, the PIC travels
toward the nucleus, gaining access via the nuclear pore com-
plex (NPC). Once within the nucleus, IN interacts with LEDGF,
a chromatin-associated factor, resulting in viral integration into
actively transcribed genes (Ciuffi et al., 2005). Recent studies
have suggested that after 4 days of infection of CD4+ T cells,
HIV-1 is found to be predominantly integrated into chromatin
located at the nuclear periphery (Marini et al., 2015).
Current models estimate that the final stages of core
uncoating occur at the NPC, with the PIC-associated proteins,
i.e., CA, being shed prior to nuclear entry (Ambrose and Aiken,
2014; Hilditch and Towers, 2014). While the existence of nuclear
PIC-associated CA is under active study, one group’s data
suggest that CA complexes with nuclear vDNA in primary mac-
rophages, but not in HeLa cells (Peng et al., 2014), while a sec-
ond work reports CA in HeLa cell nuclei (Hulme et al., 2015a).
Several findings argue that CA plays a role in the intra-nuclear
viral life cycle (Ambrose et al., 2012; Lee et al., 2010). The poly-
adenylation factor CPSF6 and the NPC proteins NUP153 and
NUP358/RANBP2 interact with CA, thereby influencing nuclear
entry and integration sites, although the mechanism is unclear
for the latter (Bhattacharya et al., 2014; Matreyek et al., 2013;
Price et al., 2012; Schaller et al., 2011). CA mutant viruses that
fail to interact with NUP358 or CPSF6 (for example, N74D/A) un-
dergo aberrant integration and, in some instances, exhibit poor
fitness (Ambrose et al., 2012; Krishnan et al., 2010; Lee et al.,
2010; Schaller et al., 2011).
The majority of these insights were obtained using established
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populations. Importantly, antibody-based imaging of HIV-1 and
fluorescence in situ hybridization (FISH) strategies to visualize
the viral RNA genome (vRNA) and vDNA (Pezzella et al., 1987;
Singer et al., 1989), as well as the use of chimeric viral proteins
(Campbell and Hope, 2008; Francis et al., 2014), also have
improved our knowledge of HIV-1 infection at a single-cell level.
Some of the acknowledged limitations of these approaches are
a lack of sensitivity and disruptive preparative conditions (i.e.,
conventional FISH) and/or an inability to readily distinguish repli-
cation-competent viruses from replication-defective viruses (i.e.,
fluorescent viral fusion proteins). Several methods address such
issues, including one employing modified dinucleotide triphos-
phates (dNTPs) that label reverse-transcribed vDNA (Peng
et al., 2014) and another using single-cell imaging of HIV provirus
(SCIP, Di Primio et al., 2013), which introduces a restriction
enzyme cut site into the vDNA, permitting proviruses to be de-
tected with an exogenous endonuclease.
In a complementary approach, we adapted existing technolo-
gies and reagents. Specifically, we use a sensitive branch-chain
DNA (bDNA) variant of FISH, ViewRNA (Yang et al., 2006), in
combination with immunolabeling using an established anti-CA
monoclonal antibody (Simm et al., 1995), to visualize events in
early HIV-1 infection in fixed cells. By combining bDNA technol-
ogy and sandwich hybridization, this approach enhances the
detection of nucleic acids (Yang et al., 2006). The ViewRNA
probes can be generated to specifically recognize much shorter
targets than traditional FISH. This approach also uses a conven-
tional confocal microscope. Among the HIV-1 life cycle events
made more appreciable with this approach, we observed that
the majority of reverse transcription occurs in the cytosolic pe-
riphery of primary macrophages and that loss of the nuclear
importer TNP03 prevents PIC nuclear entry via mislocalization
of TNP03’s cargo, the polyadenylation factor CPSF6. We find
that HIV-1 CA enters the nuclei of HeLa cells, U20S cells,
and monocyte-derived macrophages (MDMs), and it associates
in part with the vDNA, suggesting that CA plays a functional role
in HIV-1’s intra-nuclear life cycle in both primary and trans-
formed cells. Consistent with this notion, our methods show
that either the loss of CPSF6 or point mutations in CA that pre-
vent interaction with CPSF6 decreases nuclear entry as well as
the distance that the PIC penetrates into the nucleus, revealing
a viral dependency on the host for intra-nuclear trafficking
and integration into more centrally located actively transcribed
genes.
RESULTS
ViewHIV Identifies Active Viruses by Detecting De Novo
Reverse-Transcribed vDNA
In studying influenza A virus genome trafficking, we used an es-
tablished bDNA-based sandwich hybridization assay, ViewRNA
(Yang et al., 2006; Feeley et al., 2011). We estimated that this
approach might be useful for studying HIV-1 because (1) it
uses a pool of small probes that must anneal in a template-
directed manner for signal amplification to occur, (2) the small
probes can assemble on less accessible targets, and (3) the
probes anneal strand specifically so that they could be designed
to preferentially bind to the de novo synthesized vDNA of func-1718 Cell Reports 13, 1717–1731, November 24, 2015 ª2015 The Autional virions rather than the vRNA of inactive particles (Fig-
ure 1A). We created four probe sets against the indicated nucle-
otides of the cDNA of two cloned HIV-1 genomes, NL4-3 and
HX2B (Figure 1B); the targeted regions are highly homologous
across viral strains. The probe sets are denoted by the viral
genes they were designed against as follows: gag, pol (two
sets, A and B), and envelope (env).
The env probe set was used in an infection time course (Fig-
ure 1C). HeLa-T4 cells were incubated on ice with HIV-IIIB, a
CXCR-4-tropic viral population, and then warmed to 37C to
synchronize infection. At the indicated times, the cells were fixed
and permeabilized, treated with protease, heated to denature
vDNA, hybridized with the env probes, and subsequently confo-
cally imaged. The vDNA was first seen at 4–6 hr post-infection
(p.i.), increasing until 12 hr with a decrease at 24 hr. The vDNA
signals were seen in the nuclei at 6 hr, with the peak nuclear
signal at 12 hr. The mean number of vDNA signals present per
nucleus for each condition is provided based on the analysis of
R10 cells/condition over three experiments. While the exact
number of vDNA molecules per signal cannot be determined us-
ing this approach, it stands to reason that the magnitude of the
signal is proportional to the number of vDNA molecules each
one contains; thus, this approach permits a relative, rather
than absolute, comparison to be made across samples and
experiments. Control samples used heat-killed (HK) virus, an
IN inhibitor (entegravir, EVG), or an RT inhibitor (azidothymidine,
AZT). The AZT-treated samples had20-fold less vDNA signal at
12 hr p.i. than the untreated samples, indicating that the probe
preferentially recognized de novo RT products. By 24 hr p.i.,
when the majority of the HIV-1 has integrated (Butler et al.,
2001), the vDNA signal of the HIV-1 alone samples had a
9-fold decrease in vDNA signals compared to the EVG sam-
ples, suggesting that the integration of the vDNA may prevent
the probe set’s hybridization. In instances of many vDNA signals,
there may be overlap so the level detected may be an underes-
timate. The low level of vDNA in the 24 hr p.i. AZT samples was
likely from incomplete RT inhibition. These data demonstrate
that the ViewHIV assay preferentially detects the vDNA products
of functional viruses carrying out reverse transcription. Because
the ViewHIV probe only detects the newly synthesized vDNA,
and not the host DNA, this method allows the tracking over
time of the vDNA component of the PIC, from its synthesis by
RT in the cytosol to its subsequent nuclear entry.
The ViewHIV Assay Reveals that CA Enters the Nuclei of
HeLa Cells and Partially Colocalizes with vDNA
As noted, several lines of evidence point toward a nuclear role for
CA. Both the level and timing of CA dissociation from the viral
genome is a topic of active inquiry, with published data now sug-
gesting that CA enters the nuclei of MDMs andHeLa cells (Hulme
et al., 2015a; Peng et al., 2014). In a complementary effort, we
visualized CA along with the vDNA using the ViewHIV approach
in conjunction with an anti-CA antibody. We tested several anti-
bodies under the ViewHIV conditions with or without the prote-
ase treatment step (Figure S1A). Only the AG3.0 monoclonal
antibody, which detects p24 from HIV-1, HIV-2, or SIV (Simm
et al., 1995), produced a signal with or without protease treat-
ment, with the former condition providing a markedly strongerthors
Figure 1. The ViewHIV System Identifies Active Viruses by Detecting the vDNA Product of Reverse Transcription
(A) Schematic model of the ViewRNA assay. After protease treatment and heat denaturation, hybridization probes (green Zs) are annealed to the target vDNA.
Pre-amplification probes (green Ls) are used to recognize pairs of hybridization probes that have correctly annealed to adjacent sights. Amplification probes and
fluorophores build on this nexus to produce a specific amplified signal.
(B) The ViewHIV probe sets (gag, polA, polB, and env; red arrows, with the base pairs provided) were designed against regions indicated in the HIV-1 vDNA (blue
arrow). Additional arrows indicate the HIV-1 genes.
(C) HeLa-T4 cells were infected with either HIV-IIIB (HIV, MOI 350) or a heat-killed (HK) sample. Either azidothymidine (AZT) or elvitegravir (EVG) was used in
matching samples. The cells were then fixed at the indicated times. Samples were processed to detect vDNA (env VF10-10752 probe set, yellow) and host cell
DNA (DAPI, blue) and confocally imaged. Quantification of HIV-1 vDNA signals detected in the nucleus (mean ± SD) is provided and was undertaken using image
analysis software. Scale bar, 10 mm. Images from three independent experiments, with more than ten cells per experiment, were analyzed for each condition.result (Figure S1B). The baseline signal (no protease treatment) is
consistent with data from publications using the AG3.0 antibody
under similar conditions to those here (Fricke et al., 2014; Lukic
et al., 2014). In addition, only protease treatment together with
AG3.0 showed CA in the nucleus. We conclude that protease
treatment enhances a weaker baseline AG3.0 signal (Supple-
mental Experimental Procedures).
The ViewHIV assay was done in combination with anti-CA
AG3.0 immunolabeling in HeLa-T4 cells synchronously infected
with HIV-IIIB (Figure 2A). The vDNA and CA were detectable in
the cytosol, with 67% ± 8% of vDNA colocalizing with CA in theCell Repcytosol at 12 hr p.i. (Figures 2B and 2C). CA signal decreased
when an RT inhibitor, nevaripine (NVP), was used, suggesting
that the CA epitope recognized by AG3.0 is more accessible
upon reverse transcription, potentially via core uncoating. Thus,
reverse transcription and proteolysis both enhance CA detection
by AG3.0. The approach showed that CA entered the nuclei of
HeLa cells by 12 hr p.i., with the majority of intra-nuclear CA co-
localizing with vDNA (61% ± 9%, Figures 2B and 2C). These data
are inconsistent with that of Peng et al. (2014), but similar to data
from another group (Hulme et al., 2015a); such differences may
arise from the use of distinct protocols and antibodies. Stainingorts 13, 1717–1731, November 24, 2015 ª2015 The Authors 1719
Figure 2. CA Enters the Nuclei of HeLa Cells and Partially Colocalizes with vDNA
(A and B) HeLa-T4 cells were synchronously infected with HIV-IIIB (HIV, MOI 350), with or without EVG or nevarapine (NVP), and fixed at the indicated times.
Samples were processed to detect vDNA (env VF10-10752 probe set, red), HIV-1 CA (anti-CA AG3.0 antibody, green), and host cell DNA (DAPI, blue) and
confocally imaged. Scale bars, 10 mm.
(C) Quantification of HIV-1 vDNA signals colocalizing with CA (or vice versa) in the cytosol or nucleus (mean percentage colocalization ± SD) at 12 hr p.i. as
determined using image analysis software. For (A)–(C), images from three independent experiments, with eight or more cells per experiment, were analyzed for
each condition.
(D) A schematic cartoon of a representative nucleus (left) and a central z section (center) of 754- to 978-nm thickness. A 3D reconstruction of the entire nucleus
(right) was created by assembling all of the z sections that contained portions of the nucleus as determined by DAPI staining of nuclear DNA. To assess the intra-
nuclear distribution of viral signals, the central z section and 3D reconstructed nucleus were segmented into three regions as follows: peripheral nuclear (PN,
blue), middle nuclear (MN, red), and center nuclear (CN, green) regions, with the fraction of the radius (r) of the nucleus they represent provided.for the nuclear envelope protein, Lamin B1, revealed no differ-
ence in the number of viral signals (HIV-IIIB) assigned to the
nucleus using boundaries defined with either Lamin B1 or DAPI
(Figure S1C). Therefore, we used the DAPI signal to define nu-
clear boundaries throughout. We examined the possibility that
the CA detected in these assays is not brought in by the incoming
virus, but instead represents de novo protein synthesis occurring
post-infection. Assays performed with or without the protein
translation inhibitor Lactimidomycin (LACT) (Schneider-Poetsch
et al., 2010) detected no difference in CA signals (Figure S1D),
demonstrating that the CA detected is brought by the incoming
virus. These data show that CA enters the nucleus and colocal-
izes with vDNA in HeLa cells.
Determining the Best Way to Detect the Viral Signals
The Leica SP-5 confocal microscope used for this work captures
image sections in the transverse plane (xy plane, parallel to the1720 Cell Reports 13, 1717–1731, November 24, 2015 ª2015 The Auadherent surface) that are 754–978 nm deep in the z plane, de-
pending on the wavelength of light used (z sections, Figure 2D;
Experimental Procedures). For HeLa and U2OS cells, images
comprising one complete nucleus consist of 12–17 sequential
z sections, with the most centrally located z section in this stack
being defined as the central z section. To determine the best
method for the detection of viral signals, we compared the num-
ber of vDNA or CA signals detected in the central z section with
the total number of signals detected in a 3D reconstruction of the
corresponding nucleus using all of the DAPI-containing z sec-
tions (vDNA, Figures 3A–3F) or in the 3D reconstruction of the
entire cell (CA, Figures S2A–S2C), over a wide range of MOIs;
this comparison showed a near linear relationship between the
respective central z section and 3D reconstruction values. These
experiments also showed that serially diluting the viral superna-
tant led to proportional changes in the viral signals detected,
even down to the detection of a single viral signal per nucleusthors
Figure 3. Evaluation and Comparison of Viral Signals Detected with ViewHIV
(A) HeLa-MAGI cells were infected with serial dilutions of HIV-IIIB (MOI 3–500). Ratios in the legend represent the fold dilution of the viral supernatant (relative
MOI). At 24 hr the cells were fixed and processed to detect integrated proviruses (vDNA) using image analysis software from both central z sections (vDNA in
central z sections) and 3D reconstructions of the entire corresponding nucleus (vDNA in 3D nuclei). These values were plotted and a linear regression analysis
(R2 = 0.8852) was performed.
(B) Schematic of nucleus with color-coded regions (CN, green; MN, red; and PN, blue) and x, y, and z axes. Black dots represent viral signals.
(C) Schematic shows central orthogonal section in map view (left) and elevation view with perspective (right), the latter with the adherent cell surface lying in the
xy plane.
(D and E) Schematic shows a central z section (xy plane) and two corresponding central orthogonal sections (zx and zy orthogonal planes) with vDNA (red, D) or
CA (green, E) signals.
(legend continued on next page)
Cell Reports 13, 1717–1731, November 24, 2015 ª2015 The Authors 1721
or cell. Therefore, the viral signals detected in central z sections
permit comparisons over a wide range of MOIs to be made
between cells and samples, similar to the results obtained by
evaluating complete nuclei or cells.
Using the 3D nuclear reconstructions as a start, we also gener-
ated image sections that are orthogonal to the central z section
transverse plane and of comparable volumes, referred to as cen-
tral orthogonal sections (Figures 3B–3E); these would be analo-
gous to coronal plane images in an anatomic setting. This was
done to evaluate if CA and vDNA were clearly within the nucleus
in both planar surface orientations, as well as to determine in
what regions of the nucleus these viral signals were detected.
The latter analysis was structured by dividing the nucleus
into three regions of equivalent volumes as follows: peripheral
nuclear (PN), middle nuclear (MN), and central nuclear (CN,
Figure 2D; Experimental Procedures); these studies found that
CA and vDNA were detected within the nucleus using both the
central z and central orthogonal sections, and with the same
relative regional distributions (Figures 3F and S2).
To further test the validity of using the central z section for
these analyses, both the number and distribution of viral signals
(CA and vDNA) in the central orthogonal section of each nucleus
(shown as zy or zx planes, Figure S3A) were compared with
these same values obtained by analyzing the central z section
(xy plane) of the corresponding nucleus (Figures S3A–S3E); as
seenwith the 3D reconstruction versus central z section compar-
isons, both the number and position of the CA and vDNA sig-
nals were very similar between the paired central orthogonal
and central z sections. Therefore, when viral signals per nucleus
are provided in the text or figures, those values represent the sig-
nals detected in the central z section.
The ViewHIV Assay Detects CA that Partially Colocalizes
with vDNA in the Nuclei of Primary Macrophages
To determine if this approach can detect CA entering the nucleus
in cells that are relevant to HIV-1 infection in vivo, we tested the
ViewHIV assay on MDMs from patient donors. Using HIV-1 BaL
virus, a CCR5-tropic viral population, we initiated a synchronized
infection and then processed the cells at the indicated times (Fig-
ures 3G and 4A). The vDNA was detected in the untreated and
EVG samples, but not in the HK virus or NVP samples. Similar
to the data in HeLa cells, vDNA first appeared in the peripheral
cytosol of the MDMs at 4–6 hr, with the greatest level of vDNA
signals being detected at 12 hr in the untreated samples and
at 24 hr in the EVG samples (Figure 4A).
The ViewHIV probe set was used in combination with the anti-
CA antibody in assays withMDMs (Figures 3G and 4B). Similar to
HeLa cells, CA entered the nuclei of MDMs and colocalized in
part with vDNA (Figures 3G, 4B, and 4C). These data are consis-
tent with the results of Peng et al. (2014); 59% ± 10% of the
nuclear CA colocalized with vDNA (Figures 4D and S3F). Similar(F) Comparison of central z section and central orthogonal section images from (A)
provided showing proviral (vDNA) signals in a central z section (red) and a matc
panels represent the fold dilution of the viral supernatant used. DNA, blue; vDNA
(G) MDMs were synchronously infected with NL4-3 BaL virus and fixed at the indic
(green), or nuclear DNA (blue). Image analysis software was used to create cytoso
each using cells from different donors. Scale bar, 10 mM.
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by 24 hr p.i. The inhibition of integration also increased the level
of nuclear vDNA and CA. An RT inhibitor (AZT) resulted in not
only less vDNA signal but also less CA signal. We note that
although the levels of both CA and vDNA signals were consider-
ably lower in MDMs than in HeLa cells, their presence supports
the relevance of results using transformed cells.
Using the ViewHIV Approach to Evaluate the Roles of
Host Factors in HIV-1 Replication
We next assessed the usefulness of the ViewHIV approach to
investigate the role of host factors (MxB, WNK1, and COG2
and 3) in viral replication (Supplemental Experimental Proce-
dures; Figures S4A–S4H and S5A–S5G). The host factors
NUP153, TNPO3, and CPSF6 all modulate HIV-1 nuclear entry
and integration (Brass et al., 2008; Christ et al., 2008; Lee
et al., 2010). Hypotheses regarding the role of TNPO3 in HIV-1
replication include it being the nuclear importer of HIV-1, as
well as it being needed to prevent the accumulation of cytosolic
CPSF6, which binds to the PIC and prevents it from entering the
nucleus (De Iaco et al., 2013; Hilditch and Towers, 2014). There
also has been debate over what stage in viral replication
TNPO3 is needed, either before or after HIV-1 nuclear entry (De
Iaco et al., 2013).
WedepletedCPSF6alone, orwithTNPO3orNUP153, inHeLa-
T4 cells, then infected the cells with HIV-IIIB. We immunostained
for CA and CPSF6 and detected vDNA at 12 hr p.i. (Figure 5A;
0- and 12-hr samples immunostained for CSPF6 are provided;
Figures S5H and S5I). The relative percentage of nuclear entry
was quantified by determining the number of vDNA and CA par-
ticles as compared to the non-targeting (NT) controls (Figure 5B).
These experiments showed that, consistent with some reports
(Christ et al., 2008; De Iaco et al., 2013; Zhang et al., 2010),
TNPO3 and NUP153 are required for HIV-1 nuclear entry, with a
5-fold decrease in both vDNA and CA nuclear entry seen with
their loss. The levels of vDNA and CA in the nuclei were similar,
suggesting they physically associate during, and for some time
after, nuclear entry. CPSF6 depletion alone decreased viral nu-
clear entry at 12 hr p.i. by 1.8-fold. Consistent with some reports,
loss of both CPSF6 and TNPO3 resulted in restoration of viral
nuclear entry to the levels seenwith the loss of CPSF6 alone (Am-
brose et al., 2012; De Iaco et al., 2013). In contrast, loss of CPSF6
did not similarly increase nuclear entry when NUP153 was tar-
geted, indicating that the former dynamic is specific to TNPO3.
The levels of total (cytosolic and nuclear) CA and vDNA signals
were found to be similar (Figure S5J).
Immunoblotting confirmed target depletion (Figures 5C and
5D). Increasing the detector sensitivity revealed more cytosolic
CPSF6 in the TNPO3-depleted cells (Figure 5E). Quantitation
of the cytosolic colocalization between CPSF6 and CA showed
a 10-fold increase in the TNPO3-depleted cells (Figure 5F),with the nuclear periphery in white. Representative images for several MOIs are
hing central orthogonal section from the same nucleus. Ratios above the top
, red. Scale bar, 5 mM.
ated times then processed to detect vDNA (gag VF6-12978 probe set, red), CA
lic outlines (white). Images are representative of those seen in four experiments
thors
Figure 4. CA Colocalizes with vDNA in the Cytosol and Nuclei of MDMs
(A) MDMswere synchronously infected with HIV-BaL (HIV, MOI50), an HK control, or with EVG or NVP and fixed at the indicate times. Samples were processed
to detect vDNA (gag VF6-12978 probes, yellow) and host DNA (blue) and confocally imaged. Numbers show the quantification of nuclear vDNA signals (mean ±
SD). Scale bar, 10 mm.
(B) As in (A) and samples were processed for vDNA (gag VF6-12978 probe set, yellow), CA (anti-CA AG3.0, green), and host DNA (DAPI, blue) and confocally
imaged. Scale bar, 10 mm.
(legend continued on next page)
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consistent with cytosolic CPSF6 binding to CA and preventing
nuclear entry.
A 2-LTR circle assay was performed side by side (Figure 5G).
Consistent with the ViewHIV data, there was a 3-fold defect in
2-LTR circles in the absence of TNPO3, and this phenotype
was dependent on CPSF6. No loss of 2-LTR circles was seen
with CPSF6 depletion, in contrast to the ViewHIV assay data.
The 2-LTR circle assay was done at 24 hr p.i., which may allow
additional HIV-1 nuclear entry in the absence of CPSF6, as
compared to the ViewHIV assay that was done at 12 hr p.i.
When viral replication was assessed by CA staining in matched
samples after 48 hr, a decrease was seen with TNPO3 depletion
and this was dependent on CPSF6 (Figure 5H). In contrast, the
dependency of HIV-1 on NUP153 was not affected by CPSF6
levels. In keeping with previous reports, loss of CPSF6 did
consistently lower HIV-1 replication at 48 hr p.i., although the
effect was modest (Figures 5H and S5K; Ambrose et al., 2012;
Schaller et al., 2011). Interestingly, when comparing the results
of the two nuclear entry assays (ViewHIV and 2-LTR circle),
the ViewHIV assay had greater sensitivity. These data suggest
that, in the absence of TNPO3, CPSF6 remains in the cytosol
and binds to the CA portion of the PIC, thus preventing viral nu-
clear entry.
The Polyadenylation Factor CPSF6Modulates the Depth
of HIV-1 Intra-nuclear Invasion and Integration
Given thatCAandvDNAassociate innuclei, thatCAbindsCPSF6,
and that loss of CPSF6 decreases HIV-1 nuclear entry, we further
investigated how CPSF6 modulates HIV-1 replication. We
depleted U20S cells of CPSF6, then infected them with either
NL4-3 (wild-type, WT) or an isogenic NL4-3 virus containing an
N74A mutation that prevents interaction with CPSF6 (Figure 6A;
Matreyek et al., 2013). Both viruses were pseudotyped with
VSV-g protein. Equivalent RT units of each virus were used for
these experiments and this was done for all such experiments.
In cells transfected with the NT small interfering RNA (siRNA),
>85% of the N74A CA was located at or near the PN, with only
10% located in the MN, and <1% in the CN (Figures 6A and 6B;
see Figure 2D for nuclear region diagram). In contrast, the WT
CA was more evenly dispersed throughout the nucleus with
44% of the virus at the PN, 30% of the virus in the MN, and 26%
of the virus in the CN.When comparing theWT virus under condi-
tions of normal (NT) or reduced CPSF6 levels, CA was dispersed
throughout the nucleus in the NT-transfected cells. When CPSF6
was depleted, the distribution ofWTCA changed so that >85%of
theCAwasconfined to thePN,12%to theMN, andonly 1%to the
CN (Figures 6A and6C). These data showa similarity between the
effects on CA intra-nuclear migration seen with a virus that does
not interactwithCPSF6, N74A, orwith reductionofCPSF6. These
results demonstrate thatCPSF6 interactingwithCA is required for
CA’s trafficking within the nucleus.
We next investigated whether the loss of the CA-CPSF6 inter-
action also modulated the sites of viral integration into the host(C) Quantification of the percentage of the total vDNA or CA signals (nucleus and
(D) Quantification of the percentage of the nuclear vDNA signals colocalizing with C
percentage nuclear colocalization ± SD) at 12 hr p.i. is shown. Images from three
analyzed for each condition (*p% 0.05, Student’s t test).
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HIV protocol at aroundR24 hr p.i. This suggests that detection
of the integrated vDNA (proviruses) was prevented by its incor-
poration into chromatin and that a protocol more similar to the
one used for chromosomal FISHmight permit proviral detection.
We also wished to compare this approach to the SCIPmethod
for detecting proviruses (Di Primio et al., 2013). U20S cells were
transfected with either a negative control siRNA (NT) or an siRNA
targeting CPSF6. Then, 24 hr later, the cells were transfected
with the plasmid pCBASceI, which expresses the SceI restriction
enzyme. At 72 hr post-siRNA transfection, the cells were infected
with HIV-1 containing an SceI recognition site, HIV-CMV-delta-
GFP-I-SceI WT, which was pseudotyped with VSV-g. Then,
24 hr later the cells were either processed to detect proviruses
using a modified ViewHIV protocol (pressurized denaturation
step and an expanded probe set that covers the entire NL4-3
genome, Figure 6D; Table S1) or with the SCIP method (Fig-
ure 6E). Similar to the CA data, the ViewHIV approach to detect
proviruses also revealed a difference between the control cells
and the CPSF6-depleted cells, with the latter showing >70% of
the proviruses (vDNA) located at or near the PN, and only 22%
located in the MN and 0.05% in the CN (Figure 6D). In contrast,
the control cells (NT) had proviruses that were more dispersed
throughout the nucleus with 35% of the virus located at the
PN, 37% of the virus in the MN, and 28% of the virus in the
CN. In addition, the total number of proviruses was lower with
CPSF6 depletion, consistent with the defect in nuclear entry
seen earlier. When we used the SCIP assay, employing the
SceI restriction site-containing virus in conjunction with trans-
fected SceI and g-H2AX immunostaining on the cells from the
same experiments as immediately above, we observed a similar
result when CPSF6 was reduced, with 68% of the g-H2AX foci
(proviruses, integrated vDNA) detected in the PN, 23% in the
MN, and 0.09% in the CN (Figure 6E). We also assessed viral
integration after 24 hr using an additional CA mutant virus,
A105T (Lee et al., 2010), which like N74A cannot bind to
CPSF6 (Figure S6A). Similar to what was seen with CSPF6
depletion, the two mutant viruses that do not interact with
CPSF6 produced less integration events at 24 hr p.i. than WT
virus; the mutant CA viruses also were found to preferentially
integrate at the periphery of the nucleus as compared to the
WT proviruses.
To examine the distribution of PICs of the WT and N74A
mutant viruses in the same nucleus, we made two lentiviruses
differing only in that each contained a distinct non-translatable
(no start codon) reporter gene (either GFP or discoma species
red [DsRed]). We then created VSV-g pseudotyped lentiviruses
using these partial HIV-1-genomic reporter plasmids, together
with either a standard lentiviral packaging plasmid, pPAX2
(which supplies WT gag and pol in trans), or a version of
pPAX2 coding for the N74A CA mutation. The WT-DsRed and
N74A-GFP viruses were then used singly or in combination
to infect U20S cells for 12 hr (Figure S6B). These experimentscytosol) detected in the nucleus (mean ± SD) at 12 hr p.i. is shown.
A, or of the nuclear CA signals colocalizing with vDNA, in host cell nuclei (mean
experiments each using different donors, with >10 cells per experiment, were
thors
Figure 5. Evaluating the Roles of TNPO3, NUP153, and CPSF6 in HIV-1 Nuclear Entry
(A) HeLa-T4 cells were transfected with the indicated siRNAs. Then, 72 hr later, the cells were synchronously infected with HIV-IIIB (MOI300), then fixed at 12 hr
p.i. and processed to detect CA (green) and vDNA (gag VF6-12978, red). CPSF6 indicates CPSF6-1 siRNA seen in (B)–(D), (G), and (H). Image analysis software
was used to create nuclear outlines based on DAPI staining of host DNA (white). Scale bar, 5 mm.
(B) Image analysis software was used to determine the percentage of the total CA or vDNA (DNA, nucleus and cytosol) signals that were present in the host cell
nuclei after transfection with the indicated siRNAs. The values (mean ± SD) have been normalized to those of the NT control.
(legend continued on next page)
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revealed differences in PIC nuclear entry and intra-nuclear traf-
ficking between the WT-DsRed and N74A-GFP viruses similar
to those above, thereby demonstrating that the ViewHIV tech-
nique can be used to recognize distinct viral populations in the
same cell.
In an orthologous approach, we used WT CA and N74A CA
versions of pPAX2 to package the SceI site-containing viruses.
Equivalent RT units of the resulting viruses (WT CA-SceI and
N74A CA-SceI) were then used and showed that the differences
in both the number and nuclear distribution of WT and N74A
proviruses found with the ViewHIV method also were detected
using the SCIPmethod (Figure S6C). CA staining alsowas readily
appreciated at 12 hr p.i. of cells with the WT-DsRed and N74A-
GFP, again arguing against these signals arising from the de
novo translation of CA post-infection because these viruses do
not contain a gag gene (Figure S7A).
Comparable differences between the WT virus and the N74A
and A105T CA mutant viruses were obtained in studies using
either MDMs or CD4+ T cells from multiple donors (Figures 7A,
7B, S7B, and S7C). Central orthogonal sections from the nuclei
of infected CD4+ T cells demonstrated similar differences in
proviral nuclear prevalence and distribution between the WT
NL4-3 virus and the N74A CA mutant virus as those seen using
central z sections (Figures 7C and S7D). In keeping with the
data generated in HeLa cells, a near linear relationship was
detected when comparing the number of vDNA signals in the
central z sections to those found in matched 3D nuclear recon-
structions, further validating that the analysis of the central z
section represents what is occurring in the nucleus as a whole
(Figure S7E). These data reveal that the CA-CPSF6 interaction
governs (1) the level of viral nuclear entry, (2) the depth the PIC
invades into the nucleus, and (3) how deeply within the nucleus
viral integration occurs. In light of published data showing that
the N74D CA mutant viruses integrated into less actively ex-
pressed genes than WT viruses (Schaller et al., 2011) and the
known predilection of the polyadenylation factor CPSF6 for sites
of ongoing transcription, these data also support a role for intra-
nuclear CA-CPSF6 interactions facilitating HIV-1’s preference
for integration into actively transcribed genes (Figure 7D).
DISCUSSION
This work describes an image-based approach, ViewHIV, that
visualizes the early events of HIV-1 infection, from reverse tran-
scription to viral integration. Some advantages of this approach
are its use of commercially available probe sets designed against
conserved regions of the HIV-1 genome, allowing for themajority(C and D) Immunoblots of lysates from (A) and (B) using the indicated siRNAs. C
(E) HeLa-T4 cells transfected with non-targeting siRNA (NT) or siRNAs against TN
using a uniformly higher detector sensitivity than in (A). Scale bar, 2 mm.
(F) Image analysis software was used to determine the level of colocalization betw
NT control.
(G) A 2-LTR circle assay was performed using lysates from cells transfected with
the mean ± SD.
(H) HeLa-T4 cells were transfected with the indicated siRNAs for 72 hr, then infect
green) or host cell nuclei (DAPI, blue). Numbers represent the mean percentage in
experiments, with more than ten cells per experiment, were analyzed for each co
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By targeting the negative strand of the vDNA, the ViewHIV
probes preferentially detect active viruses capable of undergo-
ing reverse transcription and separate functional particles from
the greater majority of ineffective viruses. The ViewHIV signals
arise from the assembly of smaller probes, permitting evaluation
of less accessible areas (i.e., the nucleus). Similar results were
obtained for CA and cytosolic vDNA detection using antibodies
and exogenous modified nucleotides (Peng et al., 2014); like
the ViewHIV assay, this method also allows the identification of
active viruses. However, in contrast to our approach, themethod
of Peng et al. (2014) non-specifically labels all DNA being syn-
thesized within the cell, including the host’s DNA, thus making
it difficult to follow vDNA nuclear entry. The ViewHIV method
also uniquely permits the monitoring of different viruses within
the same cell using virus-specific probes.
The ViewHIV approach also visualizes integrated vDNA (provi-
ruses), a stage of the viral life cycle detected by the SCIPmethod
(Di Primio et al., 2013). A side-by-side comparison of the two
approaches in this study showed similar results and efficiencies.
A weakness of the proviral ViewHIV approach is that it does
at times detect a low level of signal near to the nucleus; this
could result from the recognition of some remaining unintegrated
vDNA or from the pressurized denaturation step extruding some
chromatin. The SCIP protocol can be done without protease
and heating steps and does not recognize unintegrated vDNA.
The ViewHIV approach can be done using clinical isolates and
without the exogenous expression of a restriction enzyme; it
also does not rely on the production of double-stranded DNA
(dsDNA) breaks, which produce background.
The ViewHIV approach detected reverse transcription in the
cytosolic periphery of HeLa cells and MDMs starting at about
4 hr p.i., and it confirmed published data showing that CA
entered the nucleus of MDMs along with vDNA (Peng et al.,
2014). However, in contrast to what was reported by Peng
et al. (2014), we also observed CA entering the nuclei of HeLa
cells, as well as U20S cells, and this nuclear CA associated
with vDNA in many instances. Hulme et al. (2015a) also have
reported CA in the nucleus of HIV-1-infected HeLa cells. We
are unsure as to why these differences occurred, but one reason
may be that the three studies used different anti-CA antibodies.
Indeed, we see a large increase in CA signal in the setting of
active reverse transcription and with the use of protease, sug-
gesting that epitope accessibility influences the detection of
CA by the AG3.0 antibody (Supplemental Experimental Proce-
dures). We note that blocking integration stabilized CA signal in
the nucleus at 24 hr p.i., suggesting that integration results inPSF6-1 and -2 indicate two distinct siRNAs.
PO3 were immunostained for CA (AG3.0, green) and CPSF6 (red) and imaged
een CA and CPSF6 in the cytosol of cells in (E). Values were normalized to the
the indicated siRNAs. Values were normalized to the NT control and represent
ed with HIV-IIIB. Then, 48 hr later, cells were stained for CA (mab183 antibody,
fection ± SD (n = 3, magnification = 43). For the above data, images from three
ndition (*p% 0.05, Student’s t test).
thors
Figure 6. CPSF6 Modulates the Depth of HIV-1 Intra-nuclear Invasion and Integration
(A) U2OS cells were transfectedwith either NT siRNA or siRNA targeting CPSF6 for 72 hr, then synchronously infected with equivalent RT units of eitherWTNL4-3
HIV-1 (MOI300) or a virus with a point mutation in the CA gene (N74A) that prevents interaction with CPSF6. Cells were fixed 12 hr p.i. and stained for CA (AG3.0
antibody, red) and nuclear DNA (blue). Scale bar, 5 mM.
(B and C) Image analysis software was used to determine the percentage of the total CA detected in each region of the nuclear regions (central z section, PN,MN,
or CN). For the WT versus N74A comparison graph (B), the values are from cells transfected with NT siRNA. Numbers represent the mean percentage ± SD.
(D) U20S cells were transfected with either a negative control (NT) or an anti-CPSF6 siRNA. Then, 24 hr later, the cells were transfected with an expression vector
containing SceI; 72 hr post-siRNA transfection, the cells were infected with an HIV-1 virus containing an SceI recognition site, HIV-CMV-delta-GFP-I-SceI,
(legend continued on next page)
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CA dissociation. Together these data demonstrate that the ge-
netic determinant of integration, CA (Krishnan et al., 2010; Lee
et al., 2010), enters the nucleus and may, therefore, act as a
physical determinant of HIV-1 migration and integration.
The ViewHIV approach also was useful in evaluating the
roles of TNPO3 and CPSF6 in HIV-1 replication. These data
are consistent with the depletion of TNPO3 resulting in excess
cytosolic CPSF6, which in turns binds to and retains HIV-1 in
the cytosol, thus inhibiting viral nuclear entry; this confirms and
expands upon published work (De Iaco et al., 2013; Figure 7D).
If CPSF6 is a conditional restriction factor that only acts under
settings of low TNPO3, why then does such an ineluctable affin-
ity exist between CA and CPSF6? Our data suggest that viral
fitness may depend on the CA-CPSF6 interaction because it
governs PIC nuclear entry as well as the distance traveled into
the nucleus prior to integration. Results supporting this were
obtained using both CPSF6 depletion and mutant viruses that
fail to interact with CPSF6. Given the CA-CPSF6 interaction
(Henning et al., 2014; Lee et al., 2010; Price et al., 2012) and
CPSF6’s role in polyadenylation, we favor a model of HIV-1 nu-
clear entry (Figure 7D) in which the PIC, via CA, interacts with
the NPC (NUP358 and NUP153). CPSF6 then binds CA as it
moves through the NPC, in conjunction with TNPO3; this ternary
interaction serves to disengage the PIC from the NPC and move
it into the nuclear periphery. TNPO3 then releases the CSPF6-
PIC complex in the nuclear periphery and returns to the cytosol.
The PIC is subsequently trafficked through the nucleus via its
interaction with CPSF6 to an actively transcribed gene produc-
ing RNAs requiring polyadenylation; the remaining CA then
dissociates and interactions between IN and LEDGF mediate
integration. This is in keeping with the role of CPSF6 in polyade-
nylation and HIV-1’s preferential integration into actively tran-
scribed genes (Craigie and Bushman, 2012). Additional support
for this model comes from the lower levels of integration into
actively transcribed genes seen with N74D viruses (Schaller
et al., 2011). Decreased integration into actively transcribed
genes also occurs with depletion of NUP358 or NUP153, both
of which interact with CA, suggesting the loss of their docking
surfaces may decrease the likelihood that the inbound CPSF6-
TNPO3 complex will correctly interact with the PIC and convey
it into the nucleus.
In this model (Figure 7D), TNPO3 is critical for preventing
CPSF6 from accumulating in the cytosol and instead shuttles
CPSF6 to the NPC-bound PIC, where it can bind to CA and
enhance HIV-1 nuclear entry. Because PIC nuclear entry is
equivalently lowered when either CPSF6 or both CPSF6 and
TNP03 are depleted, it suggests that HIV-1 can still more weakly
enter the nucleus in the absence of these factors, potentially via
CA’s interactions with the NPC alone. An additional nuclearpseudotyped with VSV-g (MOI400). The cells were fixed 24 hr p.i. and subjected
an expanded probe set (HIV NL4-3 Probe Set VF1-14734) designed to recognize i
nuclear DNA (blue). Image analysis software was used to determine the percentag
section, PN, MN, or CN). Numbers represent the mean ± SD. Scale bar, 5 mM.
(E) Cells transfected and infected side by side with those in (D) were fixed at 24
vDNA). Image analysis software was used to determine the percentage of g-H2A
mean ± SD. Scale bar, 5 mM. For the above data, numbers represent the mean ±
experimental condition were assessed(*p% 0.05, Student’s t test).
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would be predicted to be modulated downstream by CPSF6-
CA interactions. This is consistent with the N74A/D and A105T
CA-expressing viruses entering the nucleus, albeit at reduced
levels, when compared to WT virus. While there have been
competing theories as to the role of CPSF6 in HIV-1 infection,
our data together with those of others suggest that CPSF6 func-
tions as an HIV-1 dependency factor required for PIC nuclear
entry, intra-nuclear migration, and integration (Supplemental
Discussion). In conclusion, we envisage the ViewHIV approach
to continue being useful for investigating the early stages of
the viral life cycle and determining the actions of host factors
and small molecules in HIV-1 replication.
EXPERIMENTAL PROCEDURES
HIV Infections
For synchronized infections, all cells were plated on coverslips precoated with
sterile rat tail collagen (BDBiosciences) in 24-well plates (Costar). For synchro-
nized infections, cells and virus were pre-chilled on ice for 45 min before the
media were aspirated and the viral stocks added to the cells. HK virus was
heated at 85C for 15 min prior to being cooled on ice. The pre-chilled cells
were incubated with the cold virus at 4C for 45 min before being placed at
37C at time 0. At each time point, cells were washed twice with D-PBS
(Life Technologies) and put in 0.025% trypsin (Invitrogen) for 30 s. Cold
DMEM (Sigma D5671) containing 10% fetal bovine serum (FBS, Invitrogen
26140079) was used to neutralize the trypsin and wash the cells twice before
the cells were fixed for 10 min in 4% formalin (Sigma) in D-PBS. For MDM
infections, the cells were pre-treated with dNTPs in complete media for 1 hr
prior to infection. The dNTPs (Sigma: dA- D8668, dT- T1895, dC- D0776,
and dG- D7145) were kept at a stock of 50 mM (each at 50 mM) and used at
1:500. For CD4+ T cell experiments, cells were chilled on ice for 30 min, mixed
with chilled viral supernatants on ice for 40 min, and then placed at 37C and
5% CO2 for 4 hr. The cells and viral supernatant were then spun at 1,500 rpm
for 10 min and the viral supernatant aspirated, after which the cells were re-
suspended in complete T cell media with IL-2 and 6-Phosphonohexanoic
acid (PHA, see below) and placed back in the tissue culture incubator for a total
of 24 hr of infection. At the end of the 24-hr-infection period, the cells were
spun as above, the media removed, the cells were fixed for 10 min in D-PBS
with paraformaldehyde (PFA 4%, Sigma), and then washed and resuspended
with D-PBS.
Cell Culture
For confocal imaging (ViewHIV and immunostaining), HeLa-T4+ cells over-
expressing CD4 (NIH AIDS Reagent Repository 154) were plated on glass
coverslips in 24-well plates 24 hr prior to infection or transfection. HeLa cells
were grown in DMEM with 10% FBS and L-glutamine (Invitrogen 25030081).
MDMs and CD4+ T cells were from anonymous human donors per an existing
institutional review board (IRB) protocol. Each MDM and CD4+ T cell experi-
ment was performed using a unique donor’s cells. MDMs and CD4+ T cells
were purified using published methods (Zhu et al., 2014). Base media for
culturing the MDMs and CD4+ T cells were RPMI-1640 (Sigma R0883) with
10% FBS (Invitrogen 26140079) supplemented with Non-Essential Amino
Acids (Invitrogen 11140-076) and Sodium Pyruvate (Invitrogen 11360-070).to amodified ViewHIV protocol with increased heat and pressure together with
ntegrated proviral DNA (vDNA, red). Cells also were stained with DAPI to detect
e of the total integrated vDNA detected in each region of the nucleus (central z
hr p.i. and processed using the SCIP assay to detect g-H2AX foci (integrated
X foci (vDNA) detected in each region of the nucleus. Numbers represent the
SD of values derived from three experiments wherein more than ten cells per
thors
Figure 7. HIV-1 CA Mutant Viruses that Do Not Interact with CPSF6 Show Reduced Nuclear Entry and Intra-nuclear Trafficking in Primary
Immune Cells
(A) MDMswere synchronously infected with equivalent RT units of either WTNL4-3 (NL4-3, MOI400) or an N74Dmutant virus. The cells were fixed 24 hr p.i. and
then subjected to a modified ViewHIV protocol to recognize integrated DNA (vDNA, red). Cells were stained with DAPI to detect nuclear DNA (blue). Scale bar,
10 mM. Image analysis software was used to determine the percentage of the proviral DNA (vDNA) detected in each region of the nucleus (central z section, PN,
MN, or CN). Numbers represent the mean ± SD of values derived from three experiments with ten or more cells per condition assessed.
(B) Primary CD4+ T cells were stimulated with PHA then synchronously infected with equivalent RT units of either WT NL4-3 HIV-1 (NL4-3, MOI 150) or CA
mutant viruses (N74A, A105T). The T cells were fixed 24 hr p.i. and subjected to a modified ViewHIV protocol to recognize integrated vDNA (red). Cells also were
stained with DAPI to delimit the nucleus (blue). Scale bar, 10 mM. Image analysis software was used to determine the percentage of the integrated proviral DNA
(legend continued on next page)
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MDMs were differentiated in GMCSF (Roche) after plating on glass coverslips
in 24-well plates. CD4+ T cells were cultured with IL-2 (50 units/ml, Roche) and
PHA-M (5 mg/ml, Sigma L8902).
U20S cells (ATCC) were stably transduced with the Tet-On 3G activator
(Clontech Laboratories). The U20S-T3G cells were then stably transduced
with a Tet-inducible full-length MxB cDNA.
Viruses
HIV-IIIB and HIV-BaL were from NIH AIDS Reagent Repository. HIV-1 WT
NL4-3 and N74A, N74D, and A105T versions were kind gifts of Jeremy
Luban (University of Massachusetts Medical School) and Felipe Diaz-Griffero
(Albert Einstein Medical School). Pseudotyped viruses were created using the
pMD2.G plasmid (VSV-g expressing, Addgene).
The pSCE-1 site containing viral plasmid (HIV-CMV-deltaGFP-I-SceI,
SCIP method) and its use in transfections to produce infectious virus
has been described previously (Di Primio et al., 2013). The HIV-1 N74A CA
mutant version of HIV-CMV-deltaGFP-I-SceI, HIV-CMV-deltaGFP-I-SceI-
N74A, was constructed by cloning in a synthesized DNA molecule carrying
the corresponding mutation; the resultant construct, pSCE-1-N74A, was
then sequence confirmed.
The lentiviral constructs pcVPX-AcGFP-X and pcVPX-dsRed-mono-X were
chosen for imaging studies with distinct sets of ViewHIV probes targeting
either the reverse transcript of AcGFP (Clontech Laboratories, 632426) or
dsRed-monomer-N1 (Clontech Laboratories, 632465) coding sequences
(see probe section for details). These fluorophores are divergent in sequence
allowing for their simultaneous detection by their corresponding ViewHIV
specific probe sets in the absence of appreciable cross-reactivity.
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